CEMP : Summary for Cempra, Inc. - Yahoo Finance

U.S. Markets closed

Cempra, Inc. (CEMP)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.05+0.90 (+28.57%)
At close: 4:00PM EST
People also watch
TTPHESPRCLVSPTLAFOLD
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.15
Open4.12
Bid4.10 x 2800
Ask4.20 x 4000
Day's Range4.00 - 4.75
52 Week Range2.55 - 26.95
Volume21,479,201
Avg. Volume2,549,469
Market Cap212.15M
Beta0.87
PE Ratio (TTM)-1.81
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 24/7 Wall St.15 hours ago

    Top Biopharma Movers of the Past Week

    The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. However things look like they could be different in 2017.

  • American City Business Journalsyesterday

    Cempra shares up following skin infection trial results, but still a long way from full recovery

    Chapel Hill-based Cempra (CEMP) saw its shares boosted Friday after the company announced successful Phase 3 trial results of oral fusidic acid for the treatment of skin infections. The jump is a good sign for Cempra. Ahead of the FDA ruling, Cempra announced the retirement of Prabhavathi Fernandes, the company's former president and CEO.

  • 24/7 Wall St.2 days ago

    Is This the Turnaround Cempra Has Been Looking For?

    Shares of Cempra saw an incredible gain on Friday after the company announced the results from its late-stage trial for the treatment of patients with acute bacterial skin and skin structure infections....